Finally, genome-wide profiling studies have shown that ETV6/RUNX1-positive leukemias are characterized by a unique gene expression signature as compared to other genetic subtypes of human BCP-ALL with differential expression of genes involved in differentiation, apoptosis, signal transduction and immune response [17–19]. This evidence concerns the gene ETV6 and leukemia.